Mutational variation in de-novo and secondary acute myeloid Leukemia.... | Download Scientific Diagram
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Secondary acute myeloid leukemia
Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 | Haematologica
Secondary vs de novo acute myeloid leukemia
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
Frontiers | Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
Venetoclax plus intensive induction chemotherapy safe for fit, older patients with AML
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics | Leukemia
Biology of secondary leukemia
Key Topic Videos | MYLOTARG®▽(gemtuzumab ozogamicin) | PfizerPro UK
Secondary acute myeloid leukemia
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal
Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management | Tasman Medical Journal
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst - ScienceDirect
A) Incidence of De Novo, Secondary, and Therapy-Related Acute Myeloid... | Download Scientific Diagram
JCM | Free Full-Text | Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
Overall survival time in de novo AML and in t-AML. t-AML,... | Download Scientific Diagram
Outcome of patients with either de novo or secondary AML after alloSCT... | Download Scientific Diagram
